1. Home
  2. NTRA vs VIK Comparison

NTRA vs VIK Comparison

Compare NTRA & VIK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NTRA
  • VIK
  • Stock Information
  • Founded
  • NTRA 2003
  • VIK 1997
  • Country
  • NTRA United States
  • VIK Bermuda
  • Employees
  • NTRA N/A
  • VIK N/A
  • Industry
  • NTRA Medical Specialities
  • VIK
  • Sector
  • NTRA Health Care
  • VIK
  • Exchange
  • NTRA Nasdaq
  • VIK Nasdaq
  • Market Cap
  • NTRA 24.9B
  • VIK 26.4B
  • IPO Year
  • NTRA 2015
  • VIK 2024
  • Fundamental
  • Price
  • NTRA $198.93
  • VIK $60.85
  • Analyst Decision
  • NTRA Strong Buy
  • VIK Buy
  • Analyst Count
  • NTRA 17
  • VIK 12
  • Target Price
  • NTRA $196.24
  • VIK $61.25
  • AVG Volume (30 Days)
  • NTRA 1.1M
  • VIK 1.7M
  • Earning Date
  • NTRA 11-06-2025
  • VIK 11-18-2025
  • Dividend Yield
  • NTRA N/A
  • VIK N/A
  • EPS Growth
  • NTRA N/A
  • VIK N/A
  • EPS
  • NTRA N/A
  • VIK 1.57
  • Revenue
  • NTRA $1,964,250,000.00
  • VIK $5,805,889,000.00
  • Revenue This Year
  • NTRA $24.17
  • VIK $20.72
  • Revenue Next Year
  • NTRA $15.57
  • VIK $13.59
  • P/E Ratio
  • NTRA N/A
  • VIK $38.76
  • Revenue Growth
  • NTRA 44.38
  • VIK 17.71
  • 52 Week Low
  • NTRA $120.67
  • VIK $31.79
  • 52 Week High
  • NTRA $199.21
  • VIK $65.37
  • Technical
  • Relative Strength Index (RSI)
  • NTRA 73.41
  • VIK 52.39
  • Support Level
  • NTRA $188.06
  • VIK $58.31
  • Resistance Level
  • NTRA $198.99
  • VIK $61.98
  • Average True Range (ATR)
  • NTRA 6.85
  • VIK 1.68
  • MACD
  • NTRA 1.01
  • VIK -0.03
  • Stochastic Oscillator
  • NTRA 99.01
  • VIK 58.93

About NTRA Natera Inc.

Natera Inc is a diagnostic and research company with proprietary molecular and bioinformatics technology. The company's key product offerings include its Panorama Non-Invasive Prenatal Test (NIPT) which screens for chromosomal abnormalities of a fetus as well as in twin pregnancies, typically with a blood draw from the mother, Horizon Carrier Screening (HCS) to determine carrier status for a large number of severe genetic diseases that could be passed on to the carrier's children, Signatera molecular residual disease (MRD) test, which detects circulating tumor DNA in patients previously diagnosed with cancer to assess molecular residual disease and monitor for recurrence; and Prospera, to assess organ transplant rejection.

About VIK Viking Holdings Ltd Ordinary Shares

Viking Holdings Ltd is a travel company, with a fleet of 92 small ships, which view as floating hotels. It offers travel experiences on all seven continents in all three categories of the cruise industry river, ocean, and expedition cruising. The Group defines its products based on the type of cruise offering and language of the cruise service. The River segment provides river cruises outside the United States to English-speaking passengers. The Ocean segment offers ocean cruises to English-speaking passengers. Other include operating segments that are not individually reportable, consisting of expedition cruises for English-speaking passengers (Expedition), Mississippi River cruises for English-speaking passengers, and Viking China, which includes cruises for Mandarin.

Share on Social Networks: